bioAffinity Technologies BIAF
NASDAQ BIAF
$2.20 -0.14 (-5.98%)
At close: Nov 13, 2026 · 4:00 PM EST

bioAffinity Technologies (BIAF) Short-Term Debt repayments (2023 - 2026)

Updated

bioAffinity Technologies (BIAF) reported Short-Term Debt repayments of $46,109 for Q2 2026, down 37.7% from $74,024 a year earlier but up 11.5% from the prior quarter.

Analysis

bioAffinity Technologies (BIAF) Short-Term Debt repayments (2023 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, bioAffinity Technologies' Short-Term Debt repayments came in at $60,316, down 61.2% year-over-year; for FY2023, it was $251,746.

  • Five-year quarterly Short-Term Debt repayments spans a low of -$101,156 in Q3 2025 and a high of $126,096 in Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 HCA Healthcare 105.29 Bn 103.13 Bn 17.03 Bn -
2 Natera 46.06 Bn 41.68 Bn 513.47 Mn -
3 Labcorp Holdings 30.09 Bn 28.19 Bn 1.11 Bn 220.30 Mn
4 Quest Diagnostics 28.58 Bn 26.66 Bn 1.04 Bn -
5 Guardant Health 20.44 Bn 16.05 Bn 236.15 Mn -
6 BrightSpring Health Services 14.16 Bn 11.04 Bn 518.55 Mn -
7 Encompass Health 13.83 Bn 14.29 Bn 1.54 Bn -200.00 Mn
8 Tempus AI 12.69 Bn 9.84 Bn 266.70 Mn -
9 Davita 11.06 Bn 9.92 Bn 1.13 Bn -
10 bioAffinity Technologies 1.97 Mn -12.61 Mn -43,896.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 46,109.00
Mar 31, 2026 41,339.00
Sep 30, 2025 -101,156.00
Jun 30, 2025 74,024.00
Mar 31, 2025 38,927.00
Sep 30, 2023 42,334.00
Jun 30, 2023 126,096.00
Mar 31, 2023 83,316.00
API Access

bioAffinity Technologies Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=BIAF&period=max&api_key=YOUR_API_KEY